ReSound Vivia Built on decades of shared AI research and development across the GN Group, GN has pioneered a unique approach to AI that mimics the brain’s natural sound processing via a new Intelligent Focus feature to create a superior hearing experience in noise. This breakthrough technology is packed in the world’s smallest rechargeable Receiver-in-Ear […]
MENA
Beltone Debuts Latest Hearing Innovations with Beltone Envision(TM) Hearing Aids –The World’s Best Technology for Hearing in Noise And New Auracast Assistant
Designed with intelligent hearing technology, Beltone Envision AI powered hearing aids are compact yet powerful, helping individuals with hearing loss focus on hearing what matters most, even in challenging listening situations BALLERUP, Denmark, Feb. 04, 2025 (GLOBE NEWSWIRE) — Beltone proudly introduces its latest innovation: Beltone Envision™ hearing aids. Featuring the world’s best technology for hearing in noise1, […]
Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of […]
Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on long-standing relationship between the two companies In Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS, Oct. 01, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that it has entered […]
Nyxoah Announces 2024 Strategic Priorities
Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced, in anticipation of upcoming investor meetings, its strategic […]
Quantexa Partners with the Anti-Human Trafficking Intelligence Initiative (ATII) to Intensify the Fight Against Human Trafficking
Quantexa to provide category-leading AI-enabled technology, training, and industry expertise to ATII to improve how data is used in the identification and investigation of human trafficking NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) — Today, Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors, announced its official corporate sponsorship […]
EMGA Secures a Commitment for USD 30.0 Million Senior Debt Finance for Citizens Development Business Finance PLC in Sri Lanka
LONDON, Jan. 10, 2024 (GLOBE NEWSWIRE) — Emerging Markets Global Advisory LLP (EMGA), an investment bank specializing in emerging markets, has successfully secured a commitment for USD 30.0 million in senior debt finance for Citizens Development Business Finance PLC (CDB) based in Sri Lanka. EMGA originated, structured, and negotiated this financing arrangement, with the financial […]
Distinguished Scientists with Breakthroughs in Gene Therapy for Neuromuscular Diseases, and Revolutionary RNA Discoveries , Announced as King Faisal Prize Laureates in Medicine & Science
Professor Jerry Mendell and Professor Howard Chang, among other eminent figures, were selected to win the 46th session of the Prize Riyadh, Saudi Arabia, Jan. 10, 2024 (GLOBE NEWSWIRE) — Professor Jerry Mendell was announced this year’s laureate in King Faisal Prize for Medicine for his groundbreaking contributions to screening, early diagnosis, and treatment of […]